methods for ameliorating a symptom of an atopic disorder, and for treating or preventing an atopic disorder in a patient, methods for modulating igg and ige production in a cell, and relative levels of ige and igg, pharmaceutical composition, container, methods for evaluate a patient having or suspected of having an atopic disorder, and to assess a patient for the risk of an atopic disorder

摘要

METHODS FOR IMPROVING A SYMPTOM OF AN ATOPIC DISTURBUS, AND FOR TREATING OR PREVENTING AN ATOPIC DISTURBANCE IN A PATIENT, METHODS FOR MODULATING IGG AND IGE PRODUCTION IN A CELL, AND RELATED COMPUTER, IGGEOUS, IGGIOS AND IGGENT LEVELS EVALUATING A PATIENT HAVING OR SUSPECTED TO HAVE ATOPIC DISTURBANCE, AND TO ASSESS A PATIENT AT THE RISK OF AN ATOPIC DISTURBANCE An IL-21 polypeptide or other IL-21 pathway agonist may be used to treat atopic disorders, for example asthma.